GT200500111A - Acido 2-{[2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil]amino}-3-fenilpiridin-2-ilamino)propionico sustancialmente puro como inhibidor de la cinasa ikb - Google Patents
Acido 2-{[2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil]amino}-3-fenilpiridin-2-ilamino)propionico sustancialmente puro como inhibidor de la cinasa ikbInfo
- Publication number
- GT200500111A GT200500111A GT200500111A GT200500111A GT200500111A GT 200500111 A GT200500111 A GT 200500111A GT 200500111 A GT200500111 A GT 200500111A GT 200500111 A GT200500111 A GT 200500111A GT 200500111 A GT200500111 A GT 200500111A
- Authority
- GT
- Guatemala
- Prior art keywords
- substantially pure
- phenylpiridin
- methylaminopirimidin
- carbonil
- ilamino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA PRESENTE INVENCION ESTA DIRIGIDA AL COMPUESTO SUSTANCIALMENTE PURO DE FORMULA (A), O UNA SAL FARMACEUTICAMENTE ACEPTABLE, O SOLVATO DE DICHO COMPUESTO; A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UNA CANTIDAD FARMACEUTICAMENTE EFICAZ DEL COMPUESTO DE FORMULA (A), Y UN VEHICULO FARMACEUTICAMENTE ACEPTABLE; Y AL USO DE UN COMPUESTO DE FORMULA (A) QUE TIENE ACTIVIDAD COMO INHIBIDOR, PREFERIBLEMENTE UN INHIBIDOR SELECTIVO, DE IKB (IKK), EN PARTICULAR IKK2, Y A METODOS RELACIONADOS CON ELLO. T2005
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57014604P | 2004-05-12 | 2004-05-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200500111A true GT200500111A (es) | 2006-05-09 |
Family
ID=34969825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200500111A GT200500111A (es) | 2004-05-12 | 2005-05-11 | Acido 2-{[2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil]amino}-3-fenilpiridin-2-ilamino)propionico sustancialmente puro como inhibidor de la cinasa ikb |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1747215A1 (es) |
JP (1) | JP2007537266A (es) |
KR (1) | KR20070011483A (es) |
CN (1) | CN1950359A (es) |
AR (1) | AR049274A1 (es) |
AU (1) | AU2005245834A1 (es) |
BR (1) | BRPI0511029A (es) |
CA (1) | CA2566213A1 (es) |
EC (1) | ECSP066992A (es) |
GT (1) | GT200500111A (es) |
IL (1) | IL178992A0 (es) |
MA (1) | MA28553B1 (es) |
MX (1) | MXPA06012870A (es) |
NO (1) | NO20065719L (es) |
PA (1) | PA8633101A1 (es) |
PE (1) | PE20060269A1 (es) |
RU (1) | RU2006143758A (es) |
SV (1) | SV2006002111A (es) |
TN (1) | TNSN06338A1 (es) |
TW (1) | TW200605881A (es) |
UY (1) | UY28897A1 (es) |
WO (1) | WO2005113544A1 (es) |
ZA (1) | ZA200608712B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19951360A1 (de) | 1999-10-26 | 2001-05-03 | Aventis Pharma Gmbh | Substituierte Indole |
DE102004033406A1 (de) | 2004-07-10 | 2006-02-16 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung der enantiomeren Formen von 2,3-Diaminopropionsäurederivaten |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
CN104491864A (zh) | 2008-04-21 | 2015-04-08 | 奥德纳米有限公司 | 用于治疗耳部疾病和病况的耳用调配物及方法 |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2563774B1 (en) * | 2010-04-27 | 2014-03-12 | Hutchison Medipharma Limited | Pyrimidinyl indole compounds |
US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
WO2012120054A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP3478269A4 (en) | 2016-06-29 | 2020-04-08 | Otonomy, Inc. | OTIC FORMULATIONS BASED ON TRIGLYCERIDES AND THEIR USES |
CN106588803A (zh) * | 2016-11-16 | 2017-04-26 | 西南科技大学 | 一种制备5‑乙酰基异噁唑的新方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10237722A1 (de) * | 2002-08-17 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase |
-
2005
- 2005-05-11 EP EP05749733A patent/EP1747215A1/en not_active Withdrawn
- 2005-05-11 AR ARP050101914A patent/AR049274A1/es not_active Application Discontinuation
- 2005-05-11 MX MXPA06012870A patent/MXPA06012870A/es not_active Application Discontinuation
- 2005-05-11 RU RU2006143758/04A patent/RU2006143758A/ru not_active Application Discontinuation
- 2005-05-11 GT GT200500111A patent/GT200500111A/es unknown
- 2005-05-11 BR BRPI0511029-7A patent/BRPI0511029A/pt not_active IP Right Cessation
- 2005-05-11 CA CA002566213A patent/CA2566213A1/en not_active Abandoned
- 2005-05-11 JP JP2007513292A patent/JP2007537266A/ja not_active Abandoned
- 2005-05-11 WO PCT/US2005/016381 patent/WO2005113544A1/en active Application Filing
- 2005-05-11 PE PE2005000524A patent/PE20060269A1/es not_active Application Discontinuation
- 2005-05-11 AU AU2005245834A patent/AU2005245834A1/en not_active Abandoned
- 2005-05-11 KR KR1020067023661A patent/KR20070011483A/ko not_active Application Discontinuation
- 2005-05-11 CN CNA200580015046XA patent/CN1950359A/zh active Pending
- 2005-05-12 SV SV2005002111A patent/SV2006002111A/es not_active Application Discontinuation
- 2005-05-12 TW TW094115316A patent/TW200605881A/zh unknown
- 2005-05-12 UY UY28897A patent/UY28897A1/es unknown
- 2005-05-12 PA PA20058633101A patent/PA8633101A1/es unknown
-
2006
- 2006-10-18 TN TNP2006000338A patent/TNSN06338A1/en unknown
- 2006-10-18 ZA ZA200608712A patent/ZA200608712B/en unknown
- 2006-10-27 MA MA29415A patent/MA28553B1/fr unknown
- 2006-11-01 IL IL178992A patent/IL178992A0/en unknown
- 2006-11-10 EC EC2006006992A patent/ECSP066992A/es unknown
- 2006-12-12 NO NO20065719A patent/NO20065719L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ECSP066992A (es) | 2006-12-29 |
TNSN06338A1 (en) | 2008-02-22 |
PE20060269A1 (es) | 2006-05-11 |
EP1747215A1 (en) | 2007-01-31 |
AR049274A1 (es) | 2006-07-12 |
RU2006143758A (ru) | 2008-06-27 |
CA2566213A1 (en) | 2005-12-11 |
KR20070011483A (ko) | 2007-01-24 |
WO2005113544A1 (en) | 2005-12-01 |
NO20065719L (no) | 2006-12-12 |
MXPA06012870A (es) | 2007-02-15 |
IL178992A0 (en) | 2007-03-08 |
BRPI0511029A (pt) | 2007-11-27 |
SV2006002111A (es) | 2006-01-30 |
ZA200608712B (en) | 2008-06-25 |
TW200605881A (en) | 2006-02-16 |
JP2007537266A (ja) | 2007-12-20 |
MA28553B1 (fr) | 2007-04-03 |
UY28897A1 (es) | 2005-12-30 |
AU2005245834A1 (en) | 2005-12-01 |
CN1950359A (zh) | 2007-04-18 |
PA8633101A1 (es) | 2006-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200500111A (es) | Acido 2-{[2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil]amino}-3-fenilpiridin-2-ilamino)propionico sustancialmente puro como inhibidor de la cinasa ikb | |
SV2011003786A (es) | Compuestos quimicos 251 | |
ECSP088258A (es) | Inhibidores de serina proteasas | |
BRPI0507972A (pt) | composto ,composição farmacêutica , uso de um composto, método para inibição da atividade proteolìtica de uma enzima de clivagem pós prolina e composição farmacêutica embalada | |
BRPI0507654A (pt) | composição farmacêutica compreendendo um derivado de benzodiazepina e um inibidor da proteìna de fusão de rsv | |
BRPI0507617A (pt) | antagonistas de receptor de quimiocina | |
ECSP067110A (es) | Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica | |
ECSP11010948A (es) | Inhibidores de las enzimas de proteína cinasa activadas por | |
BRPI0518993A2 (pt) | composto ou um sal, solvato ou Éster farmaceuticamente aceitÁvel do mesmo, composiÇço farmacÊutica, e, uso de um composto | |
MA30725B1 (fr) | Administration d'inhibiteurs de la dipeptidyl peptidase | |
CR8102A (es) | Derivados de pirazolo- quinazolina, procedimiento para preparacion y su uso como inhibidores de quinasa | |
HN2003000044A (es) | Esteres hidroxamato del acido n - (4-fenil sustituido)-antranilico. | |
BRPI0617655A2 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica | |
UY30407A1 (es) | Derivados de [2,3,4,8-tetrahidroimidazo-[1,5-a]-pirimidin-8-il]-fenil sulfonatos sustituidos, composiciones farmacéuticas y aplicaciones. | |
AR062797A1 (es) | Derivados de piperidina como inhibidores de renina, composiciones farmaceuticas. | |
BRPI0408353A (pt) | composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto | |
EA200970851A1 (ru) | Еженедельное введение ингибиторов дипептидилпептидазы | |
WO2007101710A8 (en) | Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases | |
IL188438A (en) | A heterocyclic active drug with five benzoposes, or a pharmaceutically acceptable salt and aster salts product, as well as compounds containing them and their use as @catol - o @ - @ of @ enzyme @ dead G iltransferase @@ comtI | |
CL2007003587A1 (es) | Compuestos derivados de pirimidinas sustituidas; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para tratar o prevenir la infeccion de la hepatitis c. | |
WO2009105969A8 (zh) | 埃坡霉素类似物、其药物组合物、用途及其制备方法 | |
UY29358A1 (es) | Tiazolidinonas, su preparacion y su uso como medicamento | |
CL2004000844A1 (es) | Conjugado de derivado de wortmania-polimero soluble en agua, su proceso de preparacion; composicion farmaceutica que lo comprende; y su uso como inhibidor de la proteina fosfatidilinositol-3-quinasa para tratar el cancer de pulmon no microtico, cance | |
HN2000000045A (es) | Nuevas combinaciones farmaceuticas para inhibidores de la nos. | |
CO2018010568A2 (es) | Ácido (2s,4r)-5-(5'-cloro-2'-fluoro-[1,1'-bifenil]-4-il)-2- (etoximetil)-4-(3-hidroxiisoxazol-5-carboxamido)-2- metilpentanoico cristalino, y sus usos |